FDA Announces Joint Meeting of Advisory Committees to Discuss Peripheral and Central Nervous System Drugs and Safety Concerns

Summary

The US Food and Drug Administration (FDA) has scheduled a joint meeting of the Peripheral and Central Nervous System Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee to discuss recent developments in the field of nervous system drugs and address safety concerns.